Skip to main content
SpringerLink
Log in

Pharmacophore-Based Virtual Screening

  • Protocol
  • First Online:
Chemoinformatics and Computational Chemical Biology

Part of the book series: Methods in Molecular Biology ((MIMB,volume 672))

Abstract

This chapter is a review of the most recent developments in the field of pharmacophore modeling, covering both methodology and application. Pharmacophore-based virtual screening is nowadays a mature technology, very well accepted in the medicinal chemistry laboratory. Nevertheless, like any empirical approach, it has specific limitations and efforts to improve the methodology are still ongoing. Fundamentally, the core idea of “stripping” functional groups of their actual chemical nature in order to classify them into very few pharmacophore types, according to their dominant physico-chemical features, is both the main advantage and the main drawback of pharmacophore modeling. The advantage is the one of simplicity – the complex nature of noncovalent ligand binding interactions is rendered intuitive and comprehensible by the human mind. Although computers are much better suited for comparisons of pharmacophore patterns, a chemist’s intuition is primarily scaffold-oriented. Its underlying simplifications render pharmacophore modeling unable to provide perfect predictions of ligand binding propensities – not even if all its subsisting technical problems would be solved. Each step in pharmacophore modeling and exploitation has specific drawbacks: from insufficient or inaccurate conformational sampling to ambiguities in pharmacophore typing (mainly due to uncertainty regarding the tautomeric/protonation status of compounds), to computer time limitations in complex molecular overlay calculations, and to the choice of inappropriate anchoring points in active sites when ligand cocrystals structures are not available. Yet, imperfections notwithstanding, the approach is accurate enough in order to be practically useful and actually is the most used virtual screening technique in medicinal chemistry – notably for “scaffold hopping” approaches, allowing the discovery of new chemical classes carriers of a desired biological activity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. IUPAC. (2007) Glossary of Terms used in Medicinal Chemistry, (IUPAC, Ed.), IUPAC.

    Google Scholar 

  2. Jorgensen, W. L. (1991) Rusting of the lock and key model for protein-ligand binding. Science 254, 954–955.

    Article  PubMed  CAS  Google Scholar 

  3. Choudhury, N., Montgomery-Pettitt, B. (2007) The dewetting transition and the hydrophobic effect. Journal of the American Chemical Society 129, 4847–4852.

    Article  PubMed  CAS  Google Scholar 

  4. Thomson Reuters. (2009) ISI Web of Knowledge, New York.

    Google Scholar 

  5. Wang, C., Bradley, P., and Baker, D. (2007) Protein-protein docking with backbone flexibility. Journal of Molecular Biology 373, 503–519.

    Article  PubMed  CAS  Google Scholar 

  6. De Grandis, V., Bizzarri, A. R., and Cannistraro, S. (2007) Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin. Journal of Molecular Recognition 20, 215–226.

    Article  PubMed  CAS  Google Scholar 

  7. Guvench, O., and MacKerell, A. D., Jr. (2008) Comparison of protein force fields for molecular dynamics simulations. Methods in Molecular Biology, 63–88.

    Google Scholar 

  8. Ponder, J. W., and Case, D.A. (2003) Force fields for protein simulations. Advances in Protein Chemistry 66, 27–85.

    Article  PubMed  CAS  Google Scholar 

  9. Parent, B., Kökösy, A., and Horvath, D. (2007) Optimized evolutionary strategies in conformational sampling. Soft Computing 11, 63–79.

    Article  Google Scholar 

  10. Horvath, D. (2008) Topological Pharmacophores. in Chemoinformatics Approaches to Virtual Scrrening (Varnek, A., and Tropsha, A., Eds.), pp 44–72, RCS Publishing, Cambridge, UK.

    Chapter  Google Scholar 

  11. Bergmann, R., Linusson, A., and Zamora, I. (2007) SHOP: Scaffold HOPping by GRID-based similarity searches. Journal of Medicinal Chemistry 50, 2708–2717.

    Article  PubMed  CAS  Google Scholar 

  12. Poulain, R., Horvath, D., Bonnet, B., Eckoff, C., Chapelain, B., Bodinier, M-C., and Deprez, B. (2001) From hit to lead. Combining two complementary methods for focused library design application to μ opiate ligands. Journal of Medicinal Chemistry 44, 3378–3390.

    Article  PubMed  CAS  Google Scholar 

  13. Schlosser, J., and Rarey, M. (2009) Beyond the virtual screening paradigm: Structure-based searching for new lead compounds. Journal of Chemical Information and Modeling 49, 800–809.

    Article  PubMed  CAS  Google Scholar 

  14. Koppen, H. (2009) Virtual screening – What does it give us? Current Opinion in Drug Discovery & Development 12, 397–407.

    Google Scholar 

  15. Sun, H. M. (2008) Pharmacophore-based virtual screening. Current Medicinal Chemistry 15, 1018–1024.

    Article  PubMed  CAS  Google Scholar 

  16. Sperandio, O., Miteva, M. A., and Villoutreix, B. O. (2008) Combining ligand- and structure-based methods in drug design projects. Current Computer-Aided Drug Design 4, 250–258.

    Article  CAS  Google Scholar 

  17. Prinz, H. (2008) How to identify a pharmacophore. Chemistry & Biology 15, 207–208.

    Article  CAS  Google Scholar 

  18. Muegge, I. (2008) Synergies of virtual screening approaches. Mini-Reviews in Medicinal Chemistry 8, 927–933.

    Article  PubMed  CAS  Google Scholar 

  19. Mauser, H., and Guba, W. (2008) Recent developments in de novo design and scaffold hopping. Current Opinion in Drug Discovery & Development 11, 365–374.

    CAS  Google Scholar 

  20. Green, D. V. S. (2008) Virtual screening of chemical libraries for drug discovery. Expert Opinion on Drug Discovery 3, 1011–1026.

    Article  CAS  Google Scholar 

  21. Douguet, D. (2008) Ligand-based approaches in virtual screening. Current Computer-Aided Drug Design 4, 180–190.

    Article  CAS  Google Scholar 

  22. Van Drie, J. H. (2007) Computer-aided drug design: The next 20 years. Journal of Computer-Aided Molecular Design 21, 591–601.

    Article  PubMed  CAS  Google Scholar 

  23. McInnes, C. (2007) Virtual screening strategies in drug discovery. Current Opinion in Chemical Biology 11, 494–502.

    Article  PubMed  CAS  Google Scholar 

  24. Mason, J. S., Good, A. C., and Martin, E. J. (2001) 3-D pharmacophores in drug discovery. Current Pharmaceutical Design 7, 567–597.

    Article  PubMed  CAS  Google Scholar 

  25. Güner, O. F. (2000) Pharmacophore Perception, Use and Development in Drug Design, International University Line, La Jolla, CA.

    Google Scholar 

  26. Orts, J., Grimm, S. K., Griesinger, C., Wendt, K. U., Bartoschek, S., and Carlomagno, T. (2008) Specific methyl group protonation for the measurement of pharmacophore-specific interligand NOE interactions. Chemistry A European Journal 14, 7517–7520.

    Article  CAS  Google Scholar 

  27. Bonachera, F., Parent, B., Barbosa, F., Froloff, N., and Horvath, D. (2006) Fuzzy tricentric pharmacophore fingerprints. 1 – Topological fuzzy pharmacophore triplets and adapted molecular similarity scoring schemes. Journal of Chemical Information and Modeling 46, 2457–2477.

    Article  PubMed  CAS  Google Scholar 

  28. Guha, R., and Van Drie, J. H. (2008) Structure-activity landscape index: Identifying and quantifying activity cliffs. Journal of Chemical Information and Modeling 48, 646–658.

    Article  PubMed  CAS  Google Scholar 

  29. Maggiora, G. M. (2006) On outliers and activity cliffs – Why QSAR often disappoints. Journal of Chemical Information and Modeling 46, 1535–1535.

    Article  PubMed  CAS  Google Scholar 

  30. Bonachera, F., and Horvath, D. (2008) Fuzzy tricentric pharmacophore fingerprints. 2. Application of topological fuzzy pharmacophore triplets in quantitative structure-activity relationships. Journal of Chemical Information and Modeling 48, 409–425.

    Article  PubMed  CAS  Google Scholar 

  31. Horvath, D., Mao, B., Gozalbes, R., Barbosa, F., and Rogalski, S. L. (2004) Strengths and Limitations of Pharmacophore-Based Virtual Screening. in Chemoinformatics in Drug Discovery. (Oprea, T. I., Ed.), pp 117–137, WILEY-VCH Verlag GmbH, Weinheim.

    Google Scholar 

  32. von Korff, M., Freyss, J., and Sander, T. (2008) Flexophore, a new versatile 3D pharmacophore descriptor that considers molecular flexibility. Journal of Chemical Information and Modeling 48, 797–810.

    Article  CAS  Google Scholar 

  33. von Korff, M., Freyss, J., and Sander, T. (2008) Comparison of Ligand- and Structure-Based Virtual Screening on the DUD Data Set. in 8th International Conference on Chemical Structures, pp 209–231, Amer Chemical Soc, Noordwijkerhout, Netherlands.

    Google Scholar 

  34. Cramer, R. D., Patterson D. E., and Bunce, J. E. (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. Journal of the American Chemical Society 110, 5959–5967.

    Article  PubMed  CAS  Google Scholar 

  35. Manallack, D. T. (2008) The use of local surface properties for molecular superimposition. Journal of Molecular Modeling 14, 797–805.

    Article  PubMed  CAS  Google Scholar 

  36. Sperandio, O., Souaille, M., Delfaud, F., Miteva, M. A., and Villoutreix, B. O. (2009) MED-3DMC: A new tool to generate 3D conformation ensembles of small molecules with a Monte Carlo sampling of the conformational space. European Journal of Medicinal Chemistry 44, 1405–1409.

    Article  PubMed  CAS  Google Scholar 

  37. Liu, X. F., Bai, F., Ouyang, S. S., Wang, X. C., Li, H. L., and Jiang, H. L. (2009) Cyndi: A multi-objective evolution algorithm based method for bioactive molecular conformational generation. BMC Bioinformatics 10, 14.

    Article  CAS  Google Scholar 

  38. Li, J., Ehlers, T., Sutter, J., Varma-O’Brien, S., and Kirchmair, J. (2007) CAESAR: A new conformer generation algorithm based on recursive buildup and local rotational symmetry consideration. Journal of Chemical Information and Modeling 47, 1923–1932.

    Article  PubMed  CAS  Google Scholar 

  39. Takagi, T., Amano, M., and Tomimoto, M. (2009) Novel method for the evaluation of 3D conformation generators. Journal of Chemical Information and Modeling 49, 1377–1388.

    Article  PubMed  CAS  Google Scholar 

  40. Perola, E., and Charifson, P. S. (2004) Conformational analysis of drug-like molecules bound to proteins: An extensive study of ligand reorganization upon binding. Journal of Medicinal Chemistry 47, 2499–2510.

    Article  PubMed  CAS  Google Scholar 

  41. Böhm, H. J. (1992) The Computer Program LUDI: A new method for the de novo design of enzyme inhibitors. Journal of Computer-Aided Molecular Design 6, 61–78.

    Article  PubMed  Google Scholar 

  42. Gillet, V., Johnson, A. P., Mata, P., Sike, S., and Williams, P. (1993) SPROUT: A program for structure generation. Journal of Computer-Aided Molecular Design 7, 127–153.

    Article  PubMed  CAS  Google Scholar 

  43. Murray, C. W., Clark, D. E., Auton, T. R., Firth, M. A., Li, J., Sykes, R. A., Waszkowycz, B., Westhead, D. R., and Young, S. C. (1997) PRO_SELECT: Combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology. Journal of Computer-Aided Molecular Design 11, 193–207.

    Article  PubMed  CAS  Google Scholar 

  44. Tintori, C., Corradi, V., Magnani, M., Manetti, F., and Botta, M. (2008) Targets looking for drugs: A multistep computational protocol for the development of structure-based pharmacophores and their applications for hit discovery. Journal of Chemical Information and Modeling 48, 2166–2179.

    Article  PubMed  CAS  Google Scholar 

  45. Goodford, P. J. (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. Journal of Medicinal Chemistry 28, 849–857.

    Article  PubMed  CAS  Google Scholar 

  46. Bowman, A. L., Lerner, M. G., and Carlson, H. A. (2007) Protein flexibility and species specificity in structure-based drug discovery: Dihydrofolate reductase as a test system. Journal of the American Chemical Society 129, 3634–3640.

    Article  PubMed  CAS  Google Scholar 

  47. Damm, K. L., and Carlson, H. A. (2007) Exploring experimental sources of multiple protein conformations in structure-based drug design. Journal of the American Chemical Society 129, 8225–8235.

    Article  PubMed  CAS  Google Scholar 

  48. Jayachandran, G., Shirts, M. R., Park, S., and Pande, V. S. (2006) Parallelized over parts computation of absolute binding free energy with docking and molecular dynamics. The Journal of Chemical Physics 125, 84901–84905.

    Article  CAS  Google Scholar 

  49. Barillari, C., Marcou, G., and Rognan, D. (2008) Hot-spots-guided receptor-based pharmacophores (HS-Pharm): A knowledge-based approach to identify ligand-anchoring atoms in protein cavities and prioritize structure-based pharmacophores. Journal of Chemical Information and Modeling 48, 1396–1410.

    Article  PubMed  CAS  Google Scholar 

  50. Martin, E. J., and Sullivan, D. C. (2008) Surrogate AutoShim: Predocking into a universal ensemble kinase receptor for three dimensional activity prediction, very quickly, without a crystal structure. Journal of Chemical Information and Modeling 48, 873–881.

    Article  PubMed  CAS  Google Scholar 

  51. Zou, J., Xie, H. Z., Yang, S. Y., Chen, J. J., Ren, J. X., and Wei, Y. Q. (2008) Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2. Journal of Molecular Graphics 27, 430–438.

    Article  CAS  Google Scholar 

  52. Ebalunode, J. O., Ouyang, Z., Liang, J., and Zheng, W. (2008) Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques. Journal of Chemical Information and Modeling 48, 889–901.

    Article  PubMed  CAS  Google Scholar 

  53. Horvath, D. (2001) ComPharm – Automated comparative analysis of pharmacophoric patterns and derived QSAR approaches, novel tools in high throughput drug discovery. A proof of concept study applied to farnesyl protein transferase inhibitor design. in QSPR/QSAR Studies by Molecular Descriptors (Diudea, M. V., Ed.), pp 395–439., Nova Science Publishers, Inc, New York.

    Google Scholar 

  54. Landrum, G. A., Penzotti, J. E., and Putta, S. (2006) Feature-map vectors: A new class of informative descriptors for computational drug discovery. Journal of Computer-Aided Molecular Design 20, 751–762.

    Article  PubMed  CAS  Google Scholar 

  55. Totrov, M. (2008) Atomic property fields: Generalized 3D pharmacophoric potential for automated ligand superposition, pharmacophore elucidation and 3D QSAR. Chemical Biology & Drug Design 71, 15–27.

    Article  CAS  Google Scholar 

  56. Putta, S., Landrum, G. A., and Penzotti, J. E. (2005) Conformation mining: An algorithm for finding biologically relevant conformations. Journal of Medicinal Chemistry 48, 3313–3318.

    Article  PubMed  CAS  Google Scholar 

  57. Taminau, J., Thijs, G., and De Winter, H. (2008) Pharao: Pharmacophore alignment and optimization. Journal of Molecular Graphics & Modelling 27, 161–169.

    Article  CAS  Google Scholar 

  58. Todorov, N. P., Alberts, I. L., de Esch, I. J. P., and Dean, P. M. (2007) QUASI: A novel method for simultaneous superposition of multiple flexible ligands and virtual screening using partial similarity. Journal of Chemical Information and Modeling 47, 1007–1020.

    Article  PubMed  CAS  Google Scholar 

  59. Wolber, G., Dornhofer, A. A., and Langer, T. (2006) Efficient overlay of small organic molecules using 3D pharmacophores. Journal of Computer-Aided Molecular Design 20, 773–788.

    Article  PubMed  CAS  Google Scholar 

  60. Bandyopadhyay, D., and Agrafiotis, D. K. (2008) A self-organizing algorithm for molecular alignment and pharmacophore development. Journal of Computational Chemistry 29, 965–982.

    Article  PubMed  CAS  Google Scholar 

  61. Cottrell, S. J., Gillet, V. J., and Taylor, R. (2006) Incorporating partial matches within multiobjective pharmacophore identification. Journal of Computer-Aided Molecular Design 20, 735–749.

    Article  PubMed  CAS  Google Scholar 

  62. Nandigam, R. K., Evans, D. A., Erickson, J. A., Kim, S., and Sutherland, J. J. (2008) Predicting the Accuracy of ligand overlay methods with random forest models. Journal of Chemical Information and Modeling 48, 2386–2394.

    Article  PubMed  CAS  Google Scholar 

  63. Hähnke, V., Hofmann, B., Grgat, T., Proschak, E., Steinhilber, D., and Schneider, G. (2009) PhAST: Pharmacophore alignment search tool. Journal of Computational Chemistry 30, 761–771.

    Article  PubMed  CAS  Google Scholar 

  64. Rafael Gozalbes, F. B., Nicolaï, E., Horvath, D., Froloff, N. (2009) Development and validation of a pharmacophore-based QSAR model for the prediction of CNS activity. ChemMedChem 4, 204–209.

    Article  PubMed  CAS  Google Scholar 

  65. Mason, J. S., Morize, I., Menard, P. R., Cheney, D. L., Hulme, C., Labaudiniere, R. F. (1998) New 4-point pharmacophore method for molecular similarity and diversity applications: Overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. Journal of Medicinal Chemistry 38, 144–150.

    Google Scholar 

  66. Shepphird, J. K., and Clark, R. D. (2006) A marriage made in torsional space: Using GALAHAD models to drive pharmacophore multiplet searches. Journal of Computer-Aided Molecular Design 20, 763–771.

    Article  PubMed  CAS  Google Scholar 

  67. Sciabola, S., Morao, I., and de Groot, M. J. (2007) Pharmacophoric fingerprint method (TOPP) for 3D-QSAR modeling: Application to CYP2D6 metabolic stability. Journal of Chemical Information and Modeling 47, 76–84.

    Article  PubMed  CAS  Google Scholar 

  68. Watson, P. (2008) Naive Bayes classification using 2D pharmacophore feature triplet vectors. Journal of Chemical Information and Modeling 48, 166–178.

    Article  PubMed  CAS  Google Scholar 

  69. Askjaer, S., and Langgard, M. (2008) Combining pharmacophore fingerprints and PLS-discriminant analysis for virtual screening and SAR elucidation. Journal of Chemical Information and Modeling 48, 476–488.

    Article  PubMed  CAS  Google Scholar 

  70. Podolyan, Y., and Karypis, G. (2009) Common pharmacophore identification using frequent clique detection algorithm. Journal of Chemical Information and Modeling 49, 13–21.

    Article  PubMed  CAS  Google Scholar 

  71. Sperandio, O., Andrieu, O., Miteva, M. A., Vo, M. Q., Souaille, M., Delfaud, F., and Villoutreix, B. O. (2007) MED-SuMoLig: A new ligand-based screening tool for efficient scaffold hopping. Journal of Chemical Information and Modeling 47, 1097–1110.

    Article  PubMed  CAS  Google Scholar 

  72. Buttingsrud, B., King, R. D., and Alsberg, B. K. (2007) An alignment-free methodology for modelling field-based 3D-structure activity relationships using inductive logic programming. Journal of Chemometrics 21, 509–519.

    Article  CAS  Google Scholar 

  73. Tsunoyama, K., Amini, A., Sternberg, M. J. E., and Muggleton, S. H. (2008) Scaffold hopping in drug discovery using inductive logic programming. Journal of Chemical Information and Modeling 48, 949–957.

    Article  PubMed  CAS  Google Scholar 

  74. Schneider, G., Neidhart, W., Giller, T., and Schmid, G. (1999) “Scaffold-Hopping” by topological pharmacophore search: A contribution to virtual screening. Angewandte Chemie 38, 2894–2896.

    Article  PubMed  CAS  Google Scholar 

  75. Zhu, F. Q., and Agrafiotis, D. K. (2007) Recursive distance partitioning algorithm for common pharmacophore identification. Journal of Chemical Information and Modeling 47, 1619–1625.

    Article  PubMed  CAS  Google Scholar 

  76. Kirchmair, J., Ristic, S., Eder, K., Markt, P., Wolber, G., Laggner, C., and Langer, T. (2007) Fast and efficient in silico 3D screening: Toward maximum computational efficiency of pharmacophore-based and shape-based approaches. Journal of Chemical Information and Modeling 47, 2182–2196.

    Article  PubMed  CAS  Google Scholar 

  77. Güner, O., Clement, O., and Kurogi, Y. (2004) Pharmacophore modeling and three dimensional database searching for drug design using catalyst: Recent advances. Current Medicinal Chemistry 11, 2991–3005.

    Article  PubMed  Google Scholar 

  78. Kurogi, Y., and Güner, O. (2001) Pharmacophore modeling and threedimensional database searching for drug design using catalyst. Current Medicinal Chemistry 8, 1035–1055.

    Article  PubMed  CAS  Google Scholar 

  79. Matter, H., and Pötter, T. (1999) Comparing 3D pharmacophore triplets and 2D fingerprints for selecting diverse compound subsets. Journal of Chemical Information and Modeling 39, 1211–1225.

    Article  CAS  Google Scholar 

  80. Horvath, D., and Jeandenans, C. (2003) Neighborhood behavior of in silico structural spaces with respect to in vitro activity spaces – A benchmark for neighborhood behavior assessment of different in silico similarity metrics. Journal of Chemical Information and Computer Sciences 43, 691–698.

    Article  PubMed  CAS  Google Scholar 

  81. Fox, P. C., Wolohan, P. R. N., Abrahamian, E., and Clark, R. D. (2008) Parameterization and conformational sampling effects in pharmacophore multiplet searching. Journal of Chemical Information and Modeling 48, 2326–2334.

    Article  PubMed  CAS  Google Scholar 

  82. Nisius, B., Vogt, M., and Bajorath, J. (2009) Development of a fingerprint reduction approach for Bayesian similarity searching based on Kullback-Leibler divergence analysis. Journal of Chemical Information and Modeling 49, 1347–1358.

    Article  PubMed  CAS  Google Scholar 

  83. Kirchmair, J., Wolber, G., Laggner, C., and Langer, T. (2006) Comparative performance assessment of the conformational model generators omega and catalyst: A large-scale survey on the retrieval of protein-bound ligand conformations. Journal of Chemical Information and Modeling 46, 1848–1861.

    Article  PubMed  CAS  Google Scholar 

  84. Kirchmair, J., Laggner, C., Wolber, G., and Langer, T. (2005) Comparative analysis of protein-bound ligand conformations with respect to catalyst’s conformational space subsampling algorithms. Journal of Chemical Information and Modeling 45, 422–430.

    Article  PubMed  CAS  Google Scholar 

  85. Chen, I. J., and Foloppe, N. (2008) Conformational sampling of druglike molecules with MOE and catalyst: Implications for pharmacophore modeling and virtual screening. Journal of Chemical Information and Modeling 48, 1773–1791.

    Article  PubMed  CAS  Google Scholar 

  86. Halperin, I., Ma, B., Wolfson, H., and Nussinov, R. (2002) Principles of docking: An overview of search algorithms and a guide to scoring functions. Proteins 47, 409–443.

    Article  PubMed  CAS  Google Scholar 

  87. Jewsbury, P. J., Taylor, R. D., and Essex, J. W. (2002) A review of protein-small molecule docking methods. Journal of Computer-Aided Molecular Design 16, 151–166.

    Article  PubMed  Google Scholar 

  88. Rarey, M., Claussen, H., Buning, C., and Lengauer, T. (2001) FlexE: Efficient molecular docking considering protein structure variations. Journal of Molecular Biology 308, 377–395.

    Article  PubMed  CAS  Google Scholar 

  89. Todd, J., Ewing, A., and Kuntz, I. D. (1998) Critical evaluation of search algorithms for automated molecular docking and database screening. Journal of Computational Chemistry 18, 1175–1189.

    Google Scholar 

  90. Muthas, D., Sabnis, Y. A., Lundborg, M., and Karlen, A. (2008) Is it possible to increase hit rates in structure-based virtual screening by pharmacophore filtering? An investigation of the advantages and pitfalls of post-filtering. Journal of Molecular Graphics 26, 1237–1251.

    Article  CAS  Google Scholar 

  91. Brewerton, S. C. (2008) The use of protein-ligand interaction fingerprints in docking. Current Opinion in Drug Discovery & Development 11, 356–364.

    CAS  Google Scholar 

  92. Venhorst, J., Nunez, S., Terpstra, J. W., and Kruse, C. G. (2008) Assessment of scaffold hopping efficiency by use of molecular interaction fingerprints. Journal of Medicinal Chemistry 51, 3222–3229.

    Article  PubMed  CAS  Google Scholar 

  93. Marcou, G., and Rognan, D. (2007) Optimizing fragment and scaffold docking by use of molecular interaction fingerprints. Journal of Chemical Information and Modeling 47, 195–207.

    Article  PubMed  CAS  Google Scholar 

  94. Baroni, M., Cruciani, G., Sciabola, S., Perruccio, F., and Mason, J. S. (2007) A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): Theory and application. Journal of Chemical Information and Modeling 47, 279–294.

    Article  PubMed  CAS  Google Scholar 

  95. Horvath, D., Marcou, G., and Varnek, A. (2009) Predicting the predictability: A unified approach to the applicability domain problem of QSAR models. Journal of Chemical Information and Modeling 49, 1762–1776.

    Article  CAS  Google Scholar 

  96. Tetko, I. V., Sushko, I., Pandey, A. K., Zhu, H., Tropsha, A., Papa, E., Oberg, T., Todeschini, R., Fourches, D., and Varnek, A. (2008) Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: Focusing on applicability domain and overfitting by variable selection. Journal of Chemical Information and Modeling 48, 1733–1746.

    Article  PubMed  CAS  Google Scholar 

  97. Eriksson, L., Jaworska, J., Worth, A. P., Cronin, M., McDowell, R. M., and Gramatica, P. (2003) Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. QSAR & Combinatorial Science 111, 1361–1375.

    CAS  Google Scholar 

  98. Ma, X. H., Jia, J., Zhu, F., Xue, Y., Li, Z. R., and Chen, Y. Z. (2009) Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries. Combinatorial Chemistry & High Throughput Screening 12, 344–357.

    Article  CAS  Google Scholar 

  99. Klebe, G. (2008) Understanding QSAR: Do we always use the correct structural models to establish affinity correlation?

    Google Scholar 

  100. Gonzalez, M. P., Teran, C., Saiz-Urra, L., and Teijeira, M. (2008) Variable selection methods in QSAR: An overview. Current Topics in Medicinal Chemistry 8, 1606–1627.

    Article  PubMed  CAS  Google Scholar 

  101. Nair, P. C., and Sobhia, M. E. (2008) Fingerprint directed scaffold hopping for identification of CCR2 antagonists. Journal of Chemical Information and Modeling 48, 1891–1902.

    Article  PubMed  CAS  Google Scholar 

  102. Mascarenhas, N. M., and Ghoshal, N. (2008) An efficient tool for identifying inhibitors based on 3D-QSAR and docking using feature-shape pharmacophore of biologically active conformation – A case study with CDK2/CyclinA. European Journal of Medicinal Chemistry 43, 2807–2818.

    Article  PubMed  CAS  Google Scholar 

  103. Vadivelan, S., Sinha, B. N., Tajne, S., and Jagarlapudi, S. (2009) Fragment and knowledge-based design of selective GSK-3 beta inhibitors using virtual screening models. European Journal of Medicinal Chemistry 44, 2361–2371.

    Article  PubMed  CAS  Google Scholar 

  104. Dong, A. G., Huo, J. F., Gao, Q. Z., Zhao, K., and Wei, J. (2009) A three-dimensional pharmacophore model for RXR alpha agonists. Journal of Molecular Structure 920, 252–263.

    Article  CAS  Google Scholar 

  105. Xie, Q. Q., Xie, H. Z., Ren, J. X., Li, L. L., and Yang, S. Y. (2009) Pharmacophore modeling studies of type I and type II kinase inhibitors of Tie2. Journal of Molecular Graphics 27, 751–758.

    Article  CAS  Google Scholar 

  106. Andrade, C. H., Pasqualoto, K. F. M., Ferreira, E. I., and Hopfinger, A. J. (2009) Rational design and 3D-pharmacophore mapping of 5′-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors. Journal of Chemical Information and Modeling 49, 1070–1078.

    Article  PubMed  CAS  Google Scholar 

  107. Brizzi, A., Brizzi, V., Cascio, M. G., Corelli, F., Guida, F., Ligresti, A., Maione, S., Martinelli, A., Pasquini, S., Tuccinardi, T., and Di Marzo, V. (2009) New resorcinol-anandamide “hybrids” as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo. Journal of Medicinal Chemistry 52, 2506-2514.

    Article  PubMed  CAS  Google Scholar 

  108. Yang, H. Y., Shen, Y., Chen, J. H., Jiang, Q. F., Leng, Y., and Shen, J. H. (2009) Structure-based virtual screening for identification of novel 11 beta-HSD1 inhibitors. European Journal of Medicinal Chemistry 44, 1167–1171.

    Article  PubMed  CAS  Google Scholar 

  109. Accelrys Software, I. (2006) Catalyst, 4.9 ed., San Diego.

    Google Scholar 

  110. Wolber, G., and Langer, T. (2005) LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. Journal of Chemical Information and Modeling 45, 160–169.

    Article  PubMed  CAS  Google Scholar 

  111. Schrödinger, L. (2005) Glide, New York.

    Google Scholar 

  112. Tanrikulu, Y., Rau, O., Schwarz, O., Proschak, E., Siems, K., Muller-Kuhrt, L., Schubert-Zsilavecz, M., and Schneider, G. (2009) Structure-based pharmacophore screening for natural-product-derived PPAR gamma agonists. Chembiochem 10, 75–78.

    Article  PubMed  CAS  Google Scholar 

  113. Tanrikulu, Y., Nietert, M., Scheffer, U., Proschak, E., Grabowski, K., Schneider, P., Weidlich, M., Karas, M., Goebel, M., and Schneider, G. (2007) Scaffold hopping by “fuzzy” pharmacophores and its application to RNA targets. Chembiochem 8, 1932–1936.

    Article  PubMed  CAS  Google Scholar 

  114. Ahmed, A., Choo, H., Cho, Y. S., Park, W. K., and Pae, A. N. (2009) Identification of novel serotonin 2C receptor ligands by sequential virtual screening. Bioorganic & Medicinal Chemistry 17, 4559–4568.

    Article  CAS  Google Scholar 

  115. Raghuraman, A., Liang, A. Y., Krishnasamy, C., Lauck, T., Gunnarsson, G. T., and Desai, U. R. (2009) On designing non-saccharide, allosteric activators of antithrombin. European Journal of Medicinal Chemistry 44, 2626–2631.

    Article  PubMed  CAS  Google Scholar 

  116. Thiry, A., Ledecq, M., Cecchi, A., Frederick, R., Dogne, J. M., Supuran, C. T., Wouters, J., and Masereel, B. (2009) Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors. Bioorganic & Medicinal Chemistry 17, 553–557.

    Article  CAS  Google Scholar 

  117. (2005) MOE (Molecular Operating Environment), 2005.06 ed., Chemical Computing Group, Inc., Montreal.

    Google Scholar 

  118. Bennett, B. C., Wan, Q., Ahmad, M. F., Langan, P., and Dealwis, C. G. (2009) X-ray structure of the ternary MTX.NADPH complex of the anthrax dihydrofolate reductase: A pharmacophore for dual-site inhibitor design. Journal of Structural Biology 166, 162–171.

    Article  PubMed  CAS  Google Scholar 

  119. Tripos, I. (2007) Sybyl, 8.0 ed., St. Louis, MO.

    Google Scholar 

  120. Mustata, G., Follis, A. V., Hammoudeh, D. I., Metallo, S. J., Wang, H. B., Prochownik, E. V., Lazo, J. S., and Bahar, I. (2009) Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model. Journal of Medicinal Chemistry 52, 1247–1250.

    Article  PubMed  CAS  Google Scholar 

  121. Richmond, N. J., Abrams, C. A., Wolohan, P. R. N., Abrahamian, E., Willett, P., and Clark, R. D. (2006) GALAHAD: 1. Pharmacophore identification by hypermolecular alignment of ligands in 3D. Journal of Computer-Aided Molecular Design 20, 567–587.

    Article  PubMed  CAS  Google Scholar 

  122. Perez-Nueno, V. I., Pettersson, S., Ritchie, D. W., Borrell, J. I., and Teixido, J. (2009) Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening. Journal of Chemical Information and Modeling 49, 810–823.

    Article  PubMed  CAS  Google Scholar 

  123. Accelrys Software, I. (2007) Discovery Studio, 2.0 ed., San Diego, CA.

    Google Scholar 

  124. Lin, J., and Clark, T. (2005) An analytical, variable resolution, complete description of static molecules and their intermolecular binding properties. Journal of Chemical Information and Modeling 45, 1010–1016.

    Article  PubMed  CAS  Google Scholar 

  125. Grant, A. J., and Pickup, B. T. (1996) A fast method of molecular shape comparison: A simple application of a Gaussian description of molecular shape. Journal of Computational Chemistry 17, 1653–1659.

    Article  CAS  Google Scholar 

  126. Morris, G. M. (2007) AutoDock.

    Google Scholar 

  127. Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., and Taylor, R. D. (2003) Improved protein-ligand docking using GOLD. Proteins 52, 609–623.

    Article  PubMed  CAS  Google Scholar 

  128. McGann, M. R., Almond, H. R., Nicholls, A., Grant, J. A., and Brown, F. K. (2003) Gaussian docking functions. Biopolymers 68, 76–90.

    Article  PubMed  CAS  Google Scholar 

  129. Ritchie, D. W., and Kemp, G. J. L. (2000) Protein docking using spherical polar Fourier correlations. Proteins 39, 178–194.

    Article  PubMed  CAS  Google Scholar 

  130. Taha, M. O., Dahabiyeh, L. A., Bustanji, Y., Zalloum, H., and Saleh, S. (2008) Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors. Journal of Medicinal Chemistry 51, 6478–6494.

    Article  PubMed  CAS  Google Scholar 

  131. Abu Hammad, A. M., and Taha, M. O. (2009) Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors. Journal of Chemical Information and Modeling 49, 978–996.

    Article  PubMed  CAS  Google Scholar 

  132. Ryu, K., Kim, N. D., Choi, S. I., Han, C. K., Yoon, J. H., No, K. T., Kim, K. H., and Seong, B. L. (2009) Identification of novel inhibitors of HCV RNA-dependent RNA polymerase by pharmacophore-based virtual screening and in vitro evaluation. Bioorganic & Medicinal Chemistry 17, 2975–2982.

    Article  CAS  Google Scholar 

  133. Rolland, C., Gozalbes, R., Nicolai, E., Paugam, M. F., Coussy, L., Barbosa, F., Horvath, D., and Revah, F. (2005) G-protein-coupled receptor affinity prediction based on the use of a profiling dataset: QSAR design, synthesis, and experimental validation. Journal of Medicinal Chemistry 48, 6563–6574.

    Article  PubMed  CAS  Google Scholar 

  134. Gozalbes, R., Rolland C., Nicolaï, E., Paugam M.-F., Coussy L., Horvath D., Barbosa F., Mao B., Revah F., and Froloff, N. (2005) QSAR strategy and experimental validation for the development of a GPCR focused library. QSAR & Combinatorial Science 24, 508–516.

    Article  CAS  Google Scholar 

  135. Gozalbes, R., Barbosa, F., Nicolai, E., Horvath, D., and Froloff, N. (2009) Development and validation of a pharmacophore-based QSAR model for the prediction of CNS activity. ChemMedChem 4, 204–209.

    Article  PubMed  CAS  Google Scholar 

  136. Wei, D. G., Jiang, X. L., Zhou, L., Chen, J., Chen, Z., He, C., Yang, K., Liu, Y., Pei, J. F., and Lai, L. H. (2008) Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching. Journal of Medicinal Chemistry 51, 7882–7888.

    Article  PubMed  CAS  Google Scholar 

  137. Gimenez-Oya, V., Villacanas, O., Fernandez-Busquets, X., Rubio-Martinez, J., and Imperial, S. (2009) Mimicking direct protein-protein and solvent-mediated interactions in the CDP-methylerythritol kinase homodimer: A pharmacophore-directed virtual screening approach. Journal of Molecular Modeling 15, 997–1007.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire d’InfoChime, UMR 7177, Université de Strasbourg – CNRSInstitut de Chimie, Strasbourg, France

    Dragos Horvath

Authors
  1. Dragos Horvath
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. , Department of Life Science Informatics, Rheinische Friedrich-Wilhelms-Universitä, Dahlmannstr. 2, Bonn, 53113, Germany

    Jürgen Bajorath

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Horvath, D. (2010). Pharmacophore-Based Virtual Screening. In: Bajorath, J. (eds) Chemoinformatics and Computational Chemical Biology. Methods in Molecular Biology, vol 672. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-839-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-839-3_11

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-838-6

  • Online ISBN: 978-1-60761-839-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation